Insights & News
Discover more about ProPharma and how its dedicated team of industry-leading experts supports clients at every step through the product lifecycle.
Insights
News
Thought Leadership
ProPharma’s team of dedicated experts provides strategic guidance across the entire product lifecycle, helping pharmaceutical, biotechnology, and medical device companies navigate complex challenges with confidence. By leveraging deep industry expertise and data-driven insights, we deliver tailored solutions that support regulatory compliance, clinical development, and patient safety.
Recent Articles:
2025 Year in Review: Regulatory Shake-Ups Reshaping Pharma Promotion in 2026
2025 was a year of significant regulatory disruption. One that will have lasting implications for how pharmaceutical companies approach advertising and promotion in 2026. From an unprecedented surge in FDA enforcement activity to leadership turnover within the Office of Prescription Drug Promotion...
Understanding FDA Requirements for Medical Information Services in the US
In the highly regulated industry environment, medical information (MI) services are far more than a support function, providing information to patients, caregivers, and Healthcare Professionals; they’re a cornerstone of compliance. The Food and Drug Administration (FDA) sets clear expectations for...
Annex 11 2011 Version vs. Annex 11 2025 Draft Version: What are the Differences and Enhancements?
The GMP/GDP Inspectors Working Group and the PIC/S Committee jointly recommended that the current version of Annex 11 on Computerised Systems be revised to reflect changes in regulatory and manufacturing environments. The revised guideline should clarify requirements and expectations from...
Resources
ProPharma is committed to delivering dynamic research and perspectives crafted by world-class subject matter experts. ProPharma provides valuable insights to its clients to enable thoughtful decision making, as well as informed resource & investment allocation.
Overcoming Operational Hurdles in a High-Stakes Stroke Trial
Argenica Therapeutics’ Phase 2 acute ischaemic stroke trial faced the challenges of unpredictable patient presentation, narrow treatment windows, and demanding emergency care environments. This resulted in study timelines and data quality being at risk. ProPharma partnered closely with Argenica to...
Functional Service Provider: An Emerging Paradigm in Clinical Trial Management
As biopharma and device companies face workforce reductions, global site expansion, and increasingly intricate clinical protocols, traditional outsourcing models often fall short. The cost of standing still is steep: stalled timelines, fragmented oversight, and inconsistent data quality that can...
Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption
U.S. tariff policies are shifting fast and pharma companies dependent on global supply chains are feeling the strain. With new tariffs on APIs, excipients, and finished drug products climbing as high as 250%, the cost of inaction can be steep: disrupted supply, stalled launches, and reduced patient...
Press Room
ProPharma is at the forefront of the life sciences industry and continues to innovate and elevate its position as a pharmaceutical and MedTech service provider. Stay up to date on ProPharma's latest news and most recent announcements.
Recent Press Articles:
ProPharma Expands Operations with New Office in Hyderabad
Modern workspace supports continued growth and innovation RALEIGH, December 11, 2025 – ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, today announced the official...
ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions
Strategic Structural Update Positions ProPharma As Market Leader RALEIGH, December 4, 2025 – ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, today announced that it has...
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review
New hire elevates strategic labeling solutions to support faster approval and smarter commercialization. RALEIGH, July 8, 2025 – ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment...
Awards
With over 20 years of proven success, ProPharma continues to be acknowledged within the life sciences industry for providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. ProPharma proudly shares its recognition and achievements as its team works to improve the health and safety of patients.
Recent Awards:
ProPharma Expands Operations with New Office in Hyderabad
Modern workspace supports continued growth and innovation RALEIGH, December 11, 2025 – ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, today announced the official...
ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions
Strategic Structural Update Positions ProPharma As Market Leader RALEIGH, December 4, 2025 – ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, today announced that it has...
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review
New hire elevates strategic labeling solutions to support faster approval and smarter commercialization. RALEIGH, July 8, 2025 – ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment...
Events
ProPharma is committed to engaging with both existing and prospective clients at the right time and in the right place. Speak with a member of the team at one of these upcoming events.
Overcoming Challenges. Advancing Patient Care.
Bringing new therapies to market is more complex than ever. ProPharma helps you navigate regulatory challenges with expert guidance, ensuring compliance and accelerating patient access to life-changing treatments.